Abstract:Introduction NOD-like receptor C5 (NLRC5) plays a significant role in the immune system, and is one of the largest members of the pattern recognition receptor family. Previous studies have found that NLRC5 might be involved in the regulation of various diseases, such as fibrotic diseases and cancers; however, its effect on bone metabolism-related diseases has not been reported. Methods Skeletons of Nlrc5(-/-) mice generated by CRISPR/Cas9 and wild-type (WT) mice were compared using X-ray, micro-computed tomography, double labeling, and histological examination. Tartrate-resistant acid phosphatase and pit-absorption assays were performed to evaluate the effect of NLRC5 on osteoclasts differentiation and osteoclastic capacity. The influence of NLRC5 on osteoblasts differentiation and bone formation were studied using alkaline phosphatase and alizarin red staining, respectively. Experimental periodontitis was induced by Porphyromonas gingivalis infection and ligature to investigate the role of NLRC5 in inflammatory periodontal bone loss. Results Adenovirus-mediated NLRC5 overexpression in human bone marrow mesenchymal stem cells regulated osteogenesis positively. The femoral osteogenesis ability was significantly weakened in Nlrc5(-/-) mice. Histology showed that the area of the femoral trabeculae in the Nlrc5(-/-) mice was less than that in the WT mice, and radiology suggested that the Nlrc5(-/-) mice had fewer trabeculae and a thinner bone cortex than those of the WT mice. Nlrc5 knockout decreased osteoblast mineralization and increased osteoclastogenesis in vitro. NLRC5 was downregulated in periodontitis and P. gingivalis infection. In the experimental periodontitis model, the alveolar bone loss, inflammatory cell infiltration, and inflammatory cytokines secretion (interleukin [IL]-1 beta, IL-6, and tumor necrosis factor alpha [TNF-alpha]) in the Nlrc5(-/-) mice were significantly enhanced compared to WT mice. Conclusion We verified a novel role of NLRC5 in bone metabolism by regulating both osteoclasts activity and osteoblasts activity. Our results revealed a protective effect of NLRC5 against periodontal inflammation and alveolar bone destruction. NLRC5 could be a novel treatment target to prevent periodontal bone destruction.

NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis

NLRC5 Modulates Bone Metabolism and Plays a Role in Periodontitis.

Regulatory T cells as a potent target for controlling bone loss.

Actions of the NLRP3 and NLRC4 inflammasomes overlap in bone resorption

A Novel Inhibitor INF 39 Promotes Osteogenesis Via Blocking the NLRP3/IL-1β Axis

NDR2 is Critical for the Osteoclastogenesis by Regulating ULK1-mediated Mitophagy.

Inhibition of RIPK1/RIPK3 Ameliorates Osteoclastogenesis Through Regulating NLRP3-dependent NF-κB and MAPKs Signaling Pathways

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

The pro-inflammatory effect of NR4A3 in osteoarthritis

CYLD alleviates NLRP3 inflammasome-mediated pyroptosis in osteoporosis by deubiquitinating WNK1

DLX3 Negatively Regulates Osteoclastic Differentiation Through Microrna-124

Bone Matrix Components Activate the NLRP3 Inflammasome and Promote Osteoclast Differentiation

LncRNA Nron regulates osteoclastogenesis during orthodontic bone resorption

Lncrna Expression Profiles and the Negative Regulation of Lncrna-Nommut037835.2 in Osteoclastogenesis.

LncRNA AK077216 promotes RANKL‐induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45

NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?

Annexin A3 Accelerates Osteoclast Differentiation by Promoting the Level of RANK and TRAF6

RBP-J–Regulated Mir-182 Promotes TNF-α–Induced Osteoclastogenesis

The CD163/TWEAK/Fn14 axis: A potential therapeutic target for alleviating inflammatory bone loss

Neuroligin-3 activates Akt-dependent Nrf2 cascade to protect osteoblasts from oxidative stress

TNF-induced Osteoclastogenesis and Inflammatory Bone Resorption Are Inhibited by Transcription Factor RBP-J.